We perform an important task: the transfer of basic research results into products, which contribute to the economic and social progress.
New KDAC assay and selection system
Our technologies are as varied as the Max Planck Institutes themselves
Tacalyx Raises €7 Million in Seed Funding to Generate First in Class Anti-TACA Antibodies for Cancer Treatment
Tacalyx, a biotech company focused on the discovery and development of novel anti-TACA (Tumor ...
Do you want to receive our newsletter and press releases?